Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia M LoRusso

Showing results (1-10 of 161) with videos related to

Pageof 17
Sort By:
The Breast Journal|February 1, 2003
Capecitabine and PPE syndrome: a case reportPatricia M LoRusso
Seminars in Oncology|March 20, 2003
Phase I studies of ZD1839 in patients with common solid tumorsPatricia M Lorusso
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2009
Phase 0 clinical trials: an answer to drug development stagnation?Patricia M LoRusso
Journal of the National Cancer Institute|November 30, 2022
Improving precision oncology through better designs and reporting of biomarker-driven randomized clinical trialsPatricia M LoRusso, Boris Freidlin
Clinical Breast Cancer|December 1, 2010
The role of phosphoinositide 3-kinase in breast cancer: an overviewPatricia M LoRusso, Scott A Boerner
Expert Opinion on Investigational Drugs|June 14, 2008
Therapeutic potential of novel selective-spectrum kinase inhibitors in oncologyPatricia M Lorusso, Joseph Paul Eder
Mayo Clinic Proceedings|October 7, 2017
Twenty-First Century Precision Medicine in Oncology: Genomic Profiling in Patients With CancerMitesh J Borad, Patricia M LoRusso
Future Oncology (London, England)|December 8, 2017
Trastuzumab emtansine: determining its role in management of HER2+ breast cancerDeborah B Doroshow, Patricia M LoRusso
The New England Journal of Medicine|September 21, 2020
One Step at a Time - Clinical Evidence That KRAS Is Indeed DruggablePatricia M LoRusso, Judith S Sebolt-Leopold
Pigment Cell & Melanoma Research|November 10, 2019
Targeted therapy and immunotherapy: Emerging biomarkers in metastatic melanomaPatricia M LoRusso, Kurt Schalper, Jeffrey Sosman
Pageof 17

Showing results (1-10 of 161) with videos related to

Sort By:
Pageof 17
The Breast Journal|February 1, 2003
Capecitabine and PPE syndrome: a case reportPatricia M LoRusso
Seminars in Oncology|March 20, 2003
Phase I studies of ZD1839 in patients with common solid tumorsPatricia M Lorusso
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2009
Phase 0 clinical trials: an answer to drug development stagnation?Patricia M LoRusso
Journal of the National Cancer Institute|November 30, 2022
Improving precision oncology through better designs and reporting of biomarker-driven randomized clinical trialsPatricia M LoRusso, Boris Freidlin
Clinical Breast Cancer|December 1, 2010
The role of phosphoinositide 3-kinase in breast cancer: an overviewPatricia M LoRusso, Scott A Boerner
Expert Opinion on Investigational Drugs|June 14, 2008
Therapeutic potential of novel selective-spectrum kinase inhibitors in oncologyPatricia M Lorusso, Joseph Paul Eder
Mayo Clinic Proceedings|October 7, 2017
Twenty-First Century Precision Medicine in Oncology: Genomic Profiling in Patients With CancerMitesh J Borad, Patricia M LoRusso
Future Oncology (London, England)|December 8, 2017
Trastuzumab emtansine: determining its role in management of HER2+ breast cancerDeborah B Doroshow, Patricia M LoRusso
The New England Journal of Medicine|September 21, 2020
One Step at a Time - Clinical Evidence That KRAS Is Indeed DruggablePatricia M LoRusso, Judith S Sebolt-Leopold
Pigment Cell & Melanoma Research|November 10, 2019
Targeted therapy and immunotherapy: Emerging biomarkers in metastatic melanomaPatricia M LoRusso, Kurt Schalper, Jeffrey Sosman
Pageof 17